The GCI Dashboard

Version:
Share: whatsapp
Country Rank

40


Egypt

Recovery Rank for 180 countries/regions

Country Rank

107


Egypt

Recovery Rank for 184 countries/regions

COVID-19 Recovery Rating

3

Recovery Index
66.26
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Recovery Rating

3

Recovery Index
50.55
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Severity Rating

2

Severity Index
25.84
(Out of 100)



(0 = Best, 100 = Worst)

COVID-19 Severity Rating

1

Severity Index
19.66
(Out of 100)



(0 = Best, 100 = Worst)

Stringency Rating

4.35

(100 = Strictest Measures, 0 = No Measures)


Population
100,388,073

(Medium Density)


GNI per capita (US$)

2,800

(Lower middle income)
5 Countries who have made the most progress in
curtailing the spread of the pandemic and can be
used as examples of best practices (Relative Rating)
4
3
2 Countries who are struggling to cope with the crisis
and who may need to consider maintaining stringent
non-pharmaceutical measures (Relative Rating)
1
1 Countries who are coping with the crisis with a low percentage
of infections and resulting deaths per population
(Relative Rating)
2
3 Countries who may be overwhelmed by the crisis with a high
percentage of infections and resulting deaths per population
(Relative Rating)
4
5

Travel Advisory


1. Passengers arriving from Argentina, Australia, Bolivia, Brazil, Canada, Chile, China (People's Rep.), Colombia, Ecuador, France (Paris), Germany (Frankfurt), Guyana, Italy
(Rome), Japan, Korea (Rep.), Mexico, New-Zealand, Paraguay, Peru, Suriname, Thailand, USA, United Kingdom (London Heathrow), Uruguay or Venezuela must have: - a printed negative
COVID-19 RT-PCR test taken at most 96 hours before departure of the last direct flight to Egypt; or - a printed negative COVID-19 rapid antigen test taken at most 24 hours before
departure of the last direct flight to Egypt. The test must be based on a nasal or oral swab. The test result must have a stamp of the issuing laboratory or a QR code. A COVID-19
RT-PCR test used to depart Egypt becomes invalid for re-entry in all cases. This does not apply to: - passengers younger than 12 years; - passengers arriving directly at Hurghada
(HRG), Marsa Alam (RMF), Sharm El Sheikh (SSH) or Taba (TCP); - passengers with a COVID-19 vaccination certificate stating that they received: - the second vaccine dose of
AstraZeneca (Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before departure; or - the Janssen vaccine at least 14
days before departure. The certificate must be in Arabic, French or English and have a QR code or must be approved by the Egyptian Embassy in the country of departure; - passengers
with an electronic COVID-19 vaccination certificate issued in Egypt by the Egyptian Ministry of Health stating that they received: - the second vaccine dose of AstraZeneca
(Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before departure; or - the Janssen vaccine at least 14 days before
departure. The certificate must have the logo of the Egyptian Ministry of Health.

2. Passengers arriving from a country other than Argentina, Australia, Bolivia, Brazil, Cameroon, Canada, Chile, China (People's Rep.), Colombia, Ecuador, France (Paris), Germany
(Frankfurt), Guyana, Italy (Rome), Japan, Korea (Rep.), Mexico, New-Zealand, Paraguay, Peru, Suriname, Thailand, USA, United Kingdom (London Heathrow), Uruguay or Venezuela must
have: - a printed negative COVID-19 RT-PCR test taken at most 72 hours before departure of the last direct flight to Egypt; or - a printed negative COVID-19 rapid antigen test
taken at most 24 hours before departure of the last direct flight to Egypt. The test must be based on a nasal or oral swab. The test result must have a stamp of the issuing
laboratory or a QR code. A COVID-19 RT-PCR test used to depart Egypt becomes invalid for re-entry in all cases. This does not apply to: - passengers younger than 12 years; -
passengers arriving directly at Hurghada (HRG), Marsa Alam (RMF), Sharm El Sheikh (SSH) or Taba (TCP); - passengers with a COVID-19 vaccination certificate stating that they
received: - the second vaccine dose of AstraZeneca (Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before departure;
or - the Janssen vaccine at least 14 days before departure. The certificate must be in Arabic, French or English and have a QR code or must be approved by the Egyptian Embassy in
the country of departure; - passengers with an electronic COVID-19 vaccination certificate issued in Egypt by the Egyptian Ministry of Health stating that they received: - the
second vaccine dose of AstraZeneca (Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before departure; or - the Janssen
vaccine at least 14 days before departure. The certificate must have the logo of the Egyptian Ministry of Health.

3. Passengers arriving from Cameroon must have: - a negative COVID-19 RT-PCR test taken at most 72 hours before departure of the last direct flight to Egypt; or - a negative
COVID-19 rapid antigen test taken at most 24 hours before departure of the last direct flight to Egypt. The test must be based on a nasal or oral swab. The test result must have a
stamp of the issuing laboratory or a QR code. A COVID-19 RT-PCR test used to depart Egypt becomes invalid for re-entry in all cases. This does not apply to: - passengers younger
than 12 years; - passengers arriving directly at Hurghada (HRG), Marsa Alam (RMF), Sharm El Sheikh (SSH) or Taba (TCP); - passengers with a COVID-19 vaccination certificate stating
that they received: - the second vaccine dose of AstraZeneca (Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before
departure; or - the Janssen vaccine at least 14 days before departure. The certificate must be in Arabic, French or English and have a QR code or must be approved by the Egyptian
Embassy in the country of departure; - passengers with an electronic COVID-19 vaccination certificate issued in Egypt by the Egyptian Ministry of Health stating that they received:
- the second vaccine dose of AstraZeneca (Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before departure; or - the
Janssen vaccine at least 14 days before departure. The certificate must have the logo of the Egyptian Ministry of Health.

4. Passengers arriving directly at Hurghada (HRG), Marsa Alam (RMF), Sharm El Sheikh (SSH) or Taba (TCP) without a printed negative COVID-19 PCR or rapid antigen test result are
subject to a PCR test upon arrival at their own expense. This does not apply to: - passengers with a COVID-19 vaccination certificate stating that they received: - the second
vaccine dose of AstraZeneca (Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before departure; or - the Janssen
vaccine at least 14 days before departure. The certificate must be in Arabic, French or English and have a QR code or must be approved by the Egyptian Embassy in the country of
departure; - passengers with an electronic COVID-19 vaccination certificate issued in Egypt by the Egyptian Ministry of Health stating that they received: - the second vaccine dose
of AstraZeneca (Vaxzevria), Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac or Sputnik V at least 14 days before departure; or - the Janssen vaccine at least 14
days before departure. The certificate must have the logo of the Egyptian Ministry of Health.

5. Passengers arriving from Botswana, Eswatini, Lesotho, Mozambique, Namibia, South Africa or Zimbabwe are subject to a PCR test upon arrival at their own expense and quarantine
for 14 days.

Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)

Egypt Infection Trend


How can you tell if a curve is really flattening?

The number of daily confirmed cases has been used as an estimation of how severe the COVID-19 situation is in a given country. However, we’ve found that focusing on the country’s cumulative number of active cases gives a clearer picture of whether the infection curve is flattening.


Countries with Similar Characteristics


This table is generated by a GCI-developed tool to match countries based on their similar characteristics such as population, population density, income and climate.

Egypt 50.55 66.26 100,388,073 Medium Density Lower middle income 21-25 deg
Country Recovery Index Recovery Index Population Density GNI per capita Average Temperature
since First Case (Celsius)		 Match%
Tanzania 56.65 55.61 58,005,463 Medium Density Lower middle income 21-25 deg 100%
Kenya 55.20 55.78 52,573,973 Medium Density Lower middle income 26-30 deg 85%
Myanmar 49.30 61.83 54,045,420 Medium Density Lower middle income 26-30 deg 85%
Congo Democratic Republic 43.10 57.47 86,790,567 Medium Density Low income 26-30 deg 60%
France 57.23 53.28 67,059,887 Medium Density High income < 10 deg 60%
Germany 47.79 48.82 83,132,799 Medium Density High income < 10 deg 60%
Iran 57.95 71.96 82,913,906 Medium Density Upper middle income 11-20 deg 60%
Italy 47.65 38.68 60,297,396 Medium Density High income < 10 deg 60%
South Africa 57.89 57.52 58,558,270 Medium Density Upper middle income 11-20 deg 60%
Thailand 77.04 70.22 69,625,582 Medium Density Upper middle income 26-30 deg 60%

GCI Recovery Forecast


The GCI Recovery Forecasting methodology relies on a Monte Carlo simulation model as we recognise that the factors that contribute to an increase / decrease in confirmed COVID19 cases are highly variable and subject to various localised circumstances and interventions. The P10 / P50 / P90 are probabilities assigned to the forecasts, with P10 being highly optimistic, and P90 being very conservative on recovery and reduction in cases. The forecast model is updated daily based on the latest case data.

Forecast Results:

Situation Unchanged. No forecast as Active cases have neither increased nor decreased in the past 7 to 14 days.




Reviewed and Endorsed by:

In Collaboration and
Partnership with:

image

Recognition and Award:

Chairman's Award



Key Sponsor:

image
image
image